期刊文献+

浅谈射血分数正常的心力衰竭患者相关生物标记物

Biomarkers in patients with heart failure with normal ejection fraction
原文传递
导出
摘要 慢性心力衰竭是多种器质性心脏病发展至晚期的病理生理综合征,可分为射血分数正常和射血分数降低两类。这两类心力衰竭在心脏结构、功能、临床表现和生物标记物上均有显著差异,与射血分数降低的心力衰竭相比,目前我们对射血分数正常的心力衰竭研究甚少。本文对射血分数正常的心力衰竭患者的生物标记物加以概述。 Chronic heart failure is a pathophysiological syndrome of various organic heart disease to the late development, which can be divided into normal ejection fraction and reduced ejection fraction heart failure. These two types of heart failure have significant difference in both structure, function, clinical manifestation and biomarkers, however, little was known about the heart failure with normal ejection fraction. Henceforth, we summarized the biomarkers of heart failure with normal ejection fraction.
作者 吴炳祥
出处 《中华临床医师杂志(电子版)》 CAS 2015年第21期4-6,共3页 Chinese Journal of Clinicians(Electronic Edition)
关键词 心力衰竭 生物学标记 射血分数 Heart failure Biological markers Ejection fraction
  • 相关文献

参考文献19

  • 1Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnosediastolic heart failure: a consensus statement on the diagnosis ofheart failure with normal left ventricular ejection fraction by theHeart Failure and Achocardiography Associations of the EuropeanSociety of Cardiology[J]. Eur Heart J, 2007, 28(20): 2539-2550.
  • 2Tschope C, Kasner M, Westermann D, et al. The role of NT-proBNPin the diagnostics of isolated diastolic dysfunction: correlation withechocardiographic and invasive measurements[J]. Eur Heart J, 2005,26(21): 2277-2284.
  • 3van Veldhuisen DJ, Linssen GC, Jaarsma T, et al. B-type natriureticpeptide and prognosis in heart failure patients with preserved andreduced ejection fraction[J]. J Am Coll Cardiol, 2013, 61(14):1498-1506.
  • 4Anand IS, Rector TS, Cleland JG, et al. Prognostic value of baselineplasma amino-terminal pro-brain natriuretic peptide and itsinteractions with irbesartan treatment effects in patients with heartfailure and preserved ejection fraction: findings from theI-PRESERVE trial[J]. Circ Heart Fail, 2011, 4(5): 569-577.
  • 5Maisel A, Mueller C, Nowak R, et al. Mid-regionpro-hormonemarkersfordiagnosis and prognosis in acute dyspnea:results from the BACH (Biomarkers in Acute Heart Failure) trial[J]. JAm Coll Cardiol, 2010, 55(19): 2062-2076.
  • 6Yu CM, Cheung BM, Leung R, et al. Increase in plasmaadrenomedullin in patients with heart failure characterised bydiastolic dysfunction[J]. Heart, 2001, 86(2): 155-160.
  • 7Michowitz Y, Arbel Y, Wexler D, et al. Predictive value of highsensitivity CRP in patients with diastolic heart failure[J]. Int JCardiol, 2008, 125(3): 347-351.
  • 8Niethammer M, Sieber M, von Haehling S, et al. Inflammatorypathways in patients with heart failure and preserved ejectionfraction[J]. Int J Cardiol, 2008, 129(1): 111-117.
  • 9Matsubara J, Sugiyama S, Nozaki T, et al. Pentraxin 3 is a newinflammatory marker correlated with left ventricular diastolicdysfunction and heart failure with normal ejection fraction[J]. J AmColl Cardiol, 2011, 57(7): 861-869.
  • 10Picard F, Brehm M, Fassbach M, et al. Increased cardiac mRNAexpression of matrix metalloproteinase-1 (MMP-1) and its inhibitor(TIMP-1) in DCM patients[J]. Clin Res Cardiol, 2006, 95(5):261-269.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部